FDA Inspection 1323282 — Institut National Des Radioelements

Institut National Des Radioelements — FEI 3002807691

The FDA completed an inspection of Institut National Des Radioelements on October 8, 2024 in Fleurus. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 8, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fleurus (Belgium)

Additional Details

Mutual Recognition Agreement (MRA)